From seed stage through exit, convertible debt to reverse merger, funding strategies are critical for companies to secure the capital necessary for success. To help… Read more
Nsight Barbara Nelsen on the business of science.
On average, the cost of bringing a biologic therapy to market is $2.8 billion with a timeline of 10 years or more. As the biologics… Read more
Dividing my time between Minnesota, Boston, and Chicago means I get to meet new people and organizations every week. Here are some great connections for… Read more
Money Matters
Filed under Life science, Startup financing, Venture capitalWith JP Morgan fast approaching, as well as the Biotech Showcase and Medtech Showcases and RESI, all in the same few days of January, we have… Read more
2015 has proven a bigger year than the last for IPOs, M&As, and strategic partnerships. There’re only 16 weeks (really 14) left in this year… Read more